The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
With the FDA authorization of both Moderna and Pfizer’s COVID-19 vaccine for children between the ages of 6 months and 5, the last major phase of the U.S. vaccination roll-out is underway. This brief provides an overview of the characteristics of children under the age of 5 and discusses some issues to consider in rolling out vaccination to this age group.
Of the 19 million U.S. children under 5, half are children of color, making this group more diverse than the U.S. population overall. There is also significant variation across the country.
This report shows an increasing share of the public are frustrated about the status of COVID-19 vaccinations in the U.S.. The share of fully vaccinated adults who report receiving a booster dose has more than doubled in the last month, though vaccine uptake overall is little changed. The poll also explores attitudes towards federal mandates on workplace vaccinations and the pandemic's toll on different groups.
This report updates parents' intentions for vaccinating their children, against COVID-19, as well as their views and concerns about vaccine safety, whether their schools encourage vaccination, and how the pandemic has affected their children, mental health, and ability to afford necessities.
COVID-19 vaccine uptake among adolescents ages 12-17 has slowed after an initial wave of enthusiasm over the summer, with half (49%) of parents saying their adolescent has received at least one dose, a new KFF COVID-19 Vaccine Monitor report reveals. The share is little changed since earlier in the fall.
A surge in COVID-19 hospitalizations among people who have not been vaccinated in August is adding billions of dollars in preventable costs to the nation’s health-care system, an updated KFF analysis finds. In August, the new analysis estimates that the preventable costs of treating unvaccinated patients in hospitals total $3.
This post examines a growing COVID-19 vaccine gap in Red and Blue America, with the share of the population that have been fully vaccinated in counties that voted for President Biden in 2020 increasing more rapidly than the share in counties that voted for President Trump.
In this commentary for Barron's, Cynthia Cox explores the impact to the American public as the U.S. health insurance system adjusts to the COVID-19 pandemic. She uses the experience of the past year and a half to raise questions about broader issues of fairness in the distribution of health care costs in the country.
This analysis assesses U.S. COVID-19 vaccine dose donations in order to gauge progress towards meeting stated global vaccination goals.
Children between the ages of 6 months and 5 years of age finally became eligible for COVID-19 vaccination in the U.S. on June 18, after the Director of the Centers for Disease Control and Prevention (CDC) recommended their use for this population, following emergency use authorization granted by the Food and Drug Administration. Here, we examine the status of vaccine uptake in this group, one month into their eligibility.
© 2026 KFF